Analystreport

BridgeBio Pharma (NASDAQ:BBIO) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report